- Previous Close
56.51 - Open
56.91 - Bid 56.93 x 100
- Ask 58.19 x 100
- Day's Range
56.10 - 57.99 - 52 Week Range
40.18 - 58.41 - Volume
28,157 - Avg. Volume
40,045 - Market Cap (intraday)
728.974M - Beta (5Y Monthly) 0.80
- PE Ratio (TTM)
39.40 - EPS (TTM)
1.46 - Earnings Date Feb 6, 2025 - Feb 10, 2025
- Forward Dividend & Yield 0.60 (1.06%)
- Ex-Dividend Date Nov 15, 2024
- 1y Target Est
65.00
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with RALU ferromagnetic detection device. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.
www.iradimed.comRecent News: IRMD
View MorePerformance Overview: IRMD
Trailing total returns as of 1/14/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: IRMD
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: IRMD
View MoreValuation Measures
Market Cap
716.18M
Enterprise Value
664.72M
Trailing P/E
38.71
Forward P/E
32.89
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
10.11
Price/Book (mrq)
8.58
Enterprise Value/Revenue
9.32
Enterprise Value/EBITDA
30.01
Financial Highlights
Profitability and Income Statement
Profit Margin
26.12%
Return on Assets (ttm)
14.67%
Return on Equity (ttm)
23.58%
Revenue (ttm)
71.31M
Net Income Avi to Common (ttm)
18.63M
Diluted EPS (ttm)
1.46
Balance Sheet and Cash Flow
Total Cash (mrq)
51.72M
Total Debt/Equity (mrq)
0.32%
Levered Free Cash Flow (ttm)
13.14M